None
EN
Healthcare Marketing Influencers 2025: Charles Barkley
['Mm M Staff', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright']
MM+M – Medical Marketing and Media
If you know anything about Charles Barkley, you know he likes to talk a big game.
However, when it comes to GLP-1 drugs, the NBA Hall of Famer opts to walk the walk.
He candidly walked consumers through his GLP-1 journey, which started with Eli Lilly’s type 2 diabetes drug Mounjaro.
Now, he’s resumed his weight-loss journey thanks to Lilly’s obesity drug Zepbound.
From the August 01, 2025 Issue of MM+M - Medical Marketing and Media
['influencers'
'obesity'
'media'
'know'
'2025'
'healthcare'
'drugs'
'charles'
'glp1'
'marketing'
'lillys'
'journey'
'drug'
'barkley']